Navidea Biopharmaceuticals Announces Positive Results Encompassing Additional Patients From Its Ongoing Phase 2B Study in Rheumatoid Arthritis Nov 12, 2020
Navidea Biopharmaceuticals to Host Third Quarter 2020 Earnings Conference Call and Corporate Update Nov 5, 2020
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the American College of Rheumatology Annual Meeting Oct 9, 2020
Navidea Biopharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference Sep 8, 2020
Navidea Biopharmaceuticals Reports Second Quarter and Year-to-Date 2020 Financial Results Aug 13, 2020
Jubilant Radiopharma and Navidea Biopharmaceuticals Sign Binding Memorandum of Understanding for Commercialization Partnership Aug 10, 2020
